|
HS Code |
126402 |
| Iupac Name | 4-[4-(4-aminophenyl)piperazin-1-yl]phenol |
| Molecular Formula | C16H19N3O |
| Molecular Weight | 269.35 g/mol |
| Cas Number | 101273-27-2 |
| Appearance | White to off-white solid |
| Melting Point | 214-217°C |
| Solubility | Slightly soluble in water, soluble in DMSO and methanol |
| Smiles | c1cc(ccc1N)N2CCN(CC2)c3ccc(cc3)O |
| Inchi | InChI=1S/C16H19N3O/c17-14-3-1-12(2-4-14)19-9-7-18(8-10-19)15-5-11-16(20)13-6-15/h1-6,11,13,20H,7-10,17H2 |
As an accredited 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Brown glass bottle, 25g; sealed with screw cap. Includes hazard labeling, chemical name "4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol", and supplier details. |
| Shipping | This chemical, 4-(4-(4-Aminophenyl)piperazin-1-yl)phenol, is shipped in sealed, chemical-resistant containers to prevent contamination and moisture ingress. It is labeled according to regulatory requirements, and handled in compliance with safety protocols for amines and phenols. Delivery is typically via ground or air courier specializing in hazardous materials. |
| Storage | 4-(4-(4-Aminophenyl)piperazin-1-yl)phenol should be stored in a cool, dry, and well-ventilated area, away from sources of heat and ignition. Keep the container tightly closed, protected from moisture and direct sunlight. Store separately from oxidizing agents and strong acids. Use chemically compatible containers, and ensure the area is properly labeled and accessible only to authorized personnel. |
Competitive 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of walking the production floor have taught us that every molecule tells a story. 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol stands out as a reliable structural block in many research and development projects. Our technicians know the effort it takes to coax each batch into precise, high-purity form, using strict process controls and verified raw materials. This product reflects our commitment to process reliability, starting from the choice of precursor chemicals and finishing with our robust quality verification.
It’s tempting to paint every advanced intermediate with the same brush, yet from our vantage point, specific functional groups set this molecule apart. The piperazine ring bonded to both phenyl and aminophenyl units does not simply provide shape—it becomes the adaptive core for several research directions. Unlike more commonly produced aryl piperazine intermediates, ours features a symmetric phenolic arrangement. This extra phenolic moiety delivers greater solubility in polar environments. In multi-step syntheses—often needed in the pharmaceutical sector—the added amino group opens a gateway to functionalization that basic piperazine intermediates cannot support with ease.
Our technicians see daily how trace impurities affect reactions downstream. By maintaining batch-to-batch consistency for 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol, we help researchers avoid setbacks. We’ve invested in chromatographic and spectrometric instrumentation, not merely to tick boxes, but to keep contaminant levels at values that rarely register in competitive products. Many of our clients mention how they move forward more confidently when process uncertainties drop.
On our end, this compound gets tailored attention especially for labs designing molecules aimed at CNS targets or oncology programs. Chemists in discovery chemistry lean on the dual reactivity found in the piperazine and aminophenyl sectors. Early screening runs rely on clean coupling reactions, and this molecule’s phenolic group enhances its value in ether and carbamate formation. Experienced scientists have developed analogues for several emerging targets, finding this product’s functional groups well-positioned for solid-phase peptide coupling and linker approaches—bypassing usual solubility headaches.
Having produced aryl piperazines for over a decade, our teams have crystallized a practical understanding of the critical checkpoints. It’s never just about meeting a set of specifications. The phenolic and aminophenyl functionalities each inject different stability considerations. Shelf life, reactivity with mainstream solvents, and color stability in ambient storage environments all get regular attention. Our lot histories show clear records of impurity evolution—rarely drifting outside the single-digit ppm range for detectable byproducts. This isn’t luck; we’ve fine-tuned purification steps to match—multiple filtrations, gradient elutions, and temperature logging with every campaign.
Low trace metals, minimized residual solvents, and single-digit regional impurities make a real-world difference. Many researchers come to us with comparative HPLC traces showing secondary peaks when using third-party intermediates. We adjust crystallization cycles or filtration media to trim these peaks, because they can derail expensive NMR-based confirmation steps or introduce regulatory delays later on. Since each project moves under its own unique timeline, we stay flexible about final drying or packing—ensuring that the integrity of the batch remains as promised right until the benchwork begins.
Feedback loops drive our process improvements. Over the past year, several scale-up partners have pointed to the way this molecule behaves under different reaction atmospheres. We note any unexpected exothermic behavior or stability loss during open handling, and we feed those learnings into revised batch protocols. Unlike the generic piperazine intermediates produced in broader commodity runs, our version stays robust when exposed to routine purification steps. This allows scientists to design longer sequences without running into midstream troubleshooting caused by decomposition or inconsistent reactivity.
Researchers often bring us results that stem from subtle process differences. This phenolic piperazine handles oxidizing and reducing conditions that may stall related intermediates made under less controlled conditions. Where other products may throw off random accelerants—stalling scale-ups or producing rogue side-products—ours reliably delivers on time and on budget. Timelines in modern research rarely permit loose error margins, so our manufacturing routine adjusts to rapid project shifts, including last-minute batch tweaks or special request pack sizes.
Long before sustainability became a catchword, our production team scrutinized waste streams generated by multi-step syntheses. Handling aromatic amines requires extra safeguards, not just for compliance but for shop floor health. We adopted closed-system additions and solvent recovery to lessen both environmental impact and cost. Excess reagents generated by the phenolic coupling cycle get repurposed for in-house solvent blends—reducing net waste. Downstream from our plant, clients meet less resistance in regulatory audits when they can document the clean sourcing of synthetic intermediates.
High-value intermediates demand more than basic handling. We designed our transit protocols to prevent degradation during extremes of heat or cold—especially when shipping overseas or to research teams in remote climates. Once a rare problem, reactivity losses in uncontrolled shipping warehouses now receive closer scrutiny. By employing smart tracking and using specialized sealing, we’ve lowered incidents of transit-related batch compromise to near zero. Each outgoing batch gets visually and instrumentally inspected not just for label correctness, but for particulate uniformity and untampered seals—a process developed after real-world learning rather than speculative procedure writing.
To the untrained eye, many aryl piperazines blend together. In laboratory work, subtle molecular features distinguish performance reproducibility. The principle advantage in our 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol model lies in its enhanced polar compatibility and dual functional sites. Unlike basic N-phenylpiperazines, which see most use in lower-complexity routes, the additional phenolic group here unlocks more conjugation and extended hydrogen bonding—a trait sought after for novel linker and carrier development.
Every month we hear from teams comparing outcomes using commercial intermediates with revealed inconsistencies in reactivity, hydration states, or spectrometric profiles. We maintain strict anhydrous and oxygen-limited packing protocols, avoiding the hydrolysis risks that can kill a project’s timeline when semi-reactive phenolic sites go ignored in commodity stocks.
While the molecule often enters pharmaceutical synthetic pathways, our production data show growing usage among material science researchers. They see value in the molecule’s predictable reactivity profile. The balanced hydrophobic-hydrophilic structuring makes it suited for polymer crosslinking and surface modification. In our plant, process engineers developed custom purification steps for orders from electronic materials customers who leverage the compound’s phenolic sites for thin-film formation.
A major industry challenge lies in repeatability. We get reports from outside labs detailing time lost following up on unexplained side reactions or batch variance in apparently “identical” chemical stocks. All our runs are logged from precursor verification to final packing. Cross-reference samples are archived for at least five years, covering any audit or regulatory queries clients might encounter. That way, project teams handle scale-up and filings more confidently, with fewer supply chain hitches.
What looks like a simple workflow on a process diagram often demands real-world improvisation. The reality of handling aromatic amines in industrial quantities, especially when upscaling runs or switching reactor lines, prompts fresh control strategies. Over time, we have refined reactor charging routines, mixing rates, and filtration cycles to minimize the risk of unconverted precursors, which can be more stubborn with this particular compound than with basic piperazines. Every adjustment comes from accumulated operating history, not theoretical projections.
Having walked in the shoes of both plant chemists and R&D scientists, we build each batch with research timelines and regulatory scrutiny in mind. Customization starts with process transparency—providing real production records, impurity snapshots, and actual retention samples, not just statistical claims or pro-forma certificates. By maintaining open communication and recording every process deviation, we help clients resolve problems in real time rather than after avoidable project delays.
New application trends call for flexible, high-purity intermediates that slot into unforeseen research niches. Our team fields requests for alternate purity grades, modified particle sizes, or explorations of isotopic labeling. Each request feeds back into our process archives, securing know-how for the next wave of discovery. Our close collaboration with operations and bench scientists keeps us informed of evolving reactivity needs—sometimes requiring us to tweak solvent systems or adjust crystallization regimes.
Textbook knowledge cannot substitute for years of troubleshooting on active chemical lines. Our staff has observed, recorded, and ultimately solved problems unique to the large-scale production of phenolic piperazine derivatives. We understand which contaminants threaten downstream analytical accuracy or biological screening, and we address them in upstream filtration or extraction, avoiding late-stage project failures.
New market drivers—whether novel linker chemistries or advanced pharmaceutical libraries—demand scalable purity and robust documentation. We keep three parallel production logs: one each for plant records, QA supervision, and research lab inquiries. This three-pronged approach means that process improvements or unexpected observations move quickly to update all reference channels, not just the one most convenient for routine operators.
Each lot of this compound shows the accumulated sweat, precision, and practical experience of chemists who understand what their customers face at the bench. We take direct responsibility for quality and traceability because successful chemistry depends not just on formulas, but on the dependability of every precursor. The next project deadline rarely leaves room for product surprises, so we do our part to remove avoidable uncertainty.
Every order, whether regular or custom, draws on the same production experience and dedication to reliability. We have built our business on direct partnerships with researchers working at the edge of their fields. This product model lets us foster innovation through hands-on, transparent operations. That is the difference experience makes in bringing 4-(4-(4-Aminophenyl)Piperazin-1Yl)Phenol out of the manufacturing plant and into progressive laboratories worldwide.